Lung

Papers
(The TQCC of Lung is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It?355
ACE2: The Major Cell Entry Receptor for SARS-CoV-2300
Update 2020: Management of Non-Small Cell Lung Cancer274
Evaluation and Management of Adults with Obstructive Sleep Apnea Syndrome65
Robotic-Assisted Navigation Bronchoscopy as a Paradigm Shift in Peripheral Lung Access58
Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19?57
Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis56
Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study53
Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment41
Update 2021: Management of Small Cell Lung Cancer40
Guidelines for the Treatment of Pulmonary Arterial Hypertension38
Pulmonary Complications of Cardiac Surgery37
COVID-19 in Children with Asthma33
P2X3-Receptor Antagonists as Potential Antitussives: Summary of Current Clinical Trials in Chronic Cough31
The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer30
Tofacitinib as a Steroid-Sparing Therapy in Pulmonary Sarcoidosis, an Open-Label Prospective Proof-of-Concept Study27
Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy26
Novel Robotic-Assisted Cryobiopsy for Peripheral Pulmonary Lesions26
Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant26
Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management24
Moderate or Severe Impairment in Pulmonary Function is Associated with Mortality in Sarcoidosis Patients Infected with SARS‑CoV‑224
Strongyloides stercoralis23
Is There (Will There Be) a Post-COVID-19 Chronic Cough?22
Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials22
Cancer, Phase Angle and Sarcopenia: The Role of Diet in Connection with Lung Cancer Prognosis21
Prevalence and Outcome of Acute Respiratory Distress Syndrome in Traumatic Brain Injury: A Systematic Review and Meta-Analysis21
Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease19
Prevalence and Mortality of Pulmonary Hypertension in ESRD: A Systematic Review and Meta-analysis19
Uniportal Versus Multiportal Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: An Updated Meta-analysis18
Association Between Serum S100A8/S100A9 Heterodimer and Pulmonary Function in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease18
Prognostic Value of Geriatric Nutritional Risk Index for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis18
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough17
What is the Role of Over 100 Excipients in Over the Counter (OTC) Cough Medicines?17
Long-Term Treatment Outcomes after Behavioral Speech Therapy for Chronic Refractory Cough17
Prevalence and Severity Distribution of Type 2 Inflammation-Related Comorbidities Among Patients with Asthma, Chronic Rhinosinusitis with Nasal Polyps, and Atopic Dermatitis16
Diffuse Alveolar Hemorrhage in Cardiac Diseases15
Impact of Biologic Therapy on the Small Airways Asthma Phenotype15
Use of Thiols in the Treatment of COVID-19: Current Evidence15
Shape-Sensing Robotic-Assisted Bronchoscopy with Concurrent use of Radial Endobronchial Ultrasound and Cone Beam Computed Tomography in the Evaluation of Pulmonary Lesions15
Infectious Complications in Lung Transplant Recipients15
Follow-Up Functional Class and 6-Minute Walk Distance Identify Long-Term Survival in Pulmonary Arterial Hypertension14
Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations14
Urinary Metals, Arsenic, and Polycyclic Aromatic Hydrocarbon Exposure and Risk of Self-reported Emphysema in the US Adult Population14
Twenty-Year Reflection on the Impact of World Trade Center Exposure on Pulmonary Outcomes in Fire Department of the City of New York (FDNY) Rescue and Recovery Workers13
Prevalence and Severity of Dysphagia Using Videofluoroscopic Swallowing Study in Patients with Aspiration Pneumonia13
Cone Beam CT Guidance Improves Transbronchial Lung Cryobiopsy Safety13
Noninvasive Measurement of Pulmonary Function in Experimental Mouse Models of Airway Disease13
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia12
Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study12
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study12
Chronic Hepatitis C Virus Infection is Associated with an Increased Risk of Lung Cancer: A Systematic Review and Meta-analysis12
Objective Assessment of Cough: An Early Marker of Response to Biological Therapies in Asthma?12
Increased Th17 and Th22 Cell Percentages Predict Acute Lung Injury in Patients with Sepsis11
The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough11
Radiologic Characteristics of Non-tuberculous Mycobacteria Infection in Patients with Bronchiectasis11
Gremlin-1 for the Differential Diagnosis of Idiopathic Pulmonary Fibrosis Versus Other Interstitial Lung Diseases: A Clinical and Pathophysiological Analysis11
ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway10
Alveolar Epithelial Type 2 Cell Dysfunction in Idiopathic Pulmonary Fibrosis10
Pulmonary Embolism in Acute Asthma Exacerbation: Clinical Characteristics, Prediction Model and Hospital Outcomes9
Quantitative Pectoralis Muscle Area is Associated with the Development of Lung Cancer in a Large Lung Cancer Screening Cohort9
Progranulin and Activin A Concentrations are Elevated in Serum from Patients with Acute Exacerbations of Idiopathic Pulmonary Fibrosis9
Vaping Associated Pulmonary Nontuberculous Mycobacteria9
Impact of High-Grade Patterns in Early-Stage Lung Adenocarcinoma: A Multicentric Analysis9
Management of Chronic Cough in Adult Primary Care: A Qualitative Study9
Narrative Review of the Mechanisms and Treatment of Cough in Asthma, Cough Variant Asthma, and Non-asthmatic Eosinophilic Bronchitis9
Proposed Pathogenesis of Diffuse Alveolar Hemorrhage in Idiopathic Pulmonary Hemosiderosis9
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction9
A Survey of Physicians' Perception of the Use and Effectiveness of Diagnostic and Therapeutic Procedures in Chronic Cough Patients9
Genomic Analysis Reveals the Prognostic and Immunotherapeutic Response Characteristics of Ferroptosis in Lung Squamous Cell Carcinoma9
Irritant-induced Asthma Caused by Aerotoxic Syndrome8
Chronic Thromboembolic Pulmonary Hypertension8
Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough8
The Role of Galectins in Chronic Lung Allograft Dysfunction8
Domiciliary Cough Monitoring for the Prediction of COPD Exacerbations8
Stage I and II Small-Cell Lung Cancer—New Challenge for Surgery8
The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies8
Sleep-Disordered Breathing in Adults with Precapillary Pulmonary Hypertension: Prevalence and Predictors of Nocturnal Hypoxemia8
Gut–lung Microbiota Interactions in Chronic Obstructive Pulmonary Disease (COPD): Potential Mechanisms Driving Progression to COPD and Epidemiological Data8
Obstructive Sleep Apnea Severity, Body Mass Index, and Circulating Levels of Cellular Adhesion Molecules8
EUS-B-FNA Enhances the Diagnostic Yield of EBUS Bronchoscope for Intrathoracic Lesions8
Pulmonary Pathology Diagnoses in the US Military During the Global War on Terrorism8
A Multidisciplinary Lung Cancer Program: Does It Reduce Delay Between Diagnosis and Treatment?8
Left Upper Lobectomy for Lung Cancer as a Risk Factor for Cerebral Infarction: A Systematic Review and Meta-Analysis8
On Chronic Cough Diagnosis, Classification, and Treatment7
Poly I:C Exacerbates Airway Inflammation and Remodeling in Cigarette Smoke-Exposed Mice7
Inhalational Constrictive Bronchiolitis: The Evolution of our Understanding of this Disease7
Utility of Bronchoalveolar Lavage and Transbronchial Biopsy in Patients with Interstitial Lung Disease7
Pulmonary Arteriovenous Malformations in Non-hereditary Hemorrhagic Telangiectasia Patients: An 18-Year Retrospective Study7
Risk Factors, Prognosis, and a New Nomogram for Predicting Cancer-Specific Survival Among Lung Cancer Patients with Brain Metastasis: A Retrospective Study Based on SEER7
Eosinophilic Chronic Obstructive Pulmonary Disease7
Cough Presentation and Cough-Related Healthcare Utilization in Tertiary Care: Analysis of Routinely Collected Academic Institutional Database7
Heartburn as a Marker of the Success of Acid Suppression Therapy in Chronic Cough7
The Statistics of Counting Coughs: Easy as 1, 2, 3?7
Social Determinants of Emergency Department Visits in Mild Compared to Moderate and Severe Asthma7
Post-viral Anosmia (Loss of Sensation of Smell) Did Not Begin with COVID-19!7
Association of Xpert MTB/RIF Cycle Threshold Values with Tuberculosis Treatment Outcomes7
The Relationship Between Cough Reflex Sensitivity and Exacerbation Frequency in Chronic Obstructive Pulmonary Disease7
Cough in the Elderly During the COVID-19 Pandemic7
Nationwide Real-Life Safety and Treatment Exposure Data on Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III, Locally Advanced, Non-small Cell Lung Cancer: Analysis of Patients E7
Risk Factors for Cytomegalovirus Reactivation in Lung Transplant Recipients7
0.020746231079102